1. Search Result

Search Result

Results for "920113-03-7" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-16559
    Riviciclib hydrochloride


    CDK Apoptosis Cancer
    Riviciclib hydrochloride (P276-00) is a potent cyclin-dependent kinase (CDK) inhibitor, which inhibits CDK9-cyclinT1, CDK4-cyclin D1, and CDK1-cyclinB with IC50s of 20 nM, 63 nM, and 79 nM, respectively. Riviciclib hydrochloride (P276-00) shows antitumor activity on cisplatin-resistant cells.